Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Ibalizumab Biosimilar - Anti-CD4 D3 domain mAb - Research Grade |
---|---|
Source | CAS 680188-33-4 |
Species | Humanized |
Expression system | Mammalian cells |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Ibalizumab,Hu5A8,TMB-355,TNX-355,CD4 D3 domain,anti-CD4 D3 domain |
Reference | PX-TA1174 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG4-kappa |
Clonality | Monoclonal Antibody |
Immobilized CD4 Protein - T-cell surface glycoprotein CD4(CD4) (cat. No. PX-P4702) at 0.5µg/mL (100µL/well) can bind Ibalizumab Biosimilar - Anti-CD4 D3 domain mAb (cat. No. PX-TA1174) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 2.551M.
Ibalizumab Biosimilar - Anti-CD4 D3 domain mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Reviews
Il n’y a pas encore d’avis.